Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
Communications Chemistry|January 25, 2023
Exploring the phase stability in interpenetrated diamondoid covalent organic frameworksSander Borgmans, Sven M J Rogge, Juul S De Vos, et al.Leukemia Research|January 1, 1995
Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levelsS Pakkala, S de Vos, E Elstner, et al.Addiction (Abingdon, England)|January 26, 2013
Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?Anneke S de Vos, Jannie J van der Helm, Amy Matser, et al.Chemosphere|September 11, 2004
Accumulation and tissue distribution of selected polychlorinated biphenyl congeners in chickensJ Maervoet, S G Chu, S De Vos, et al.Prenatal Diagnosis|March 1, 1997
Full monosomy 21, prenatally diagnosed by fluorescent in situ hybridizationA M Joosten, S De Vos, D Van Opstal, et al.BMJ Quality & Safety|July 23, 2018
Connecting perspectives on quality and safety: patient-level linkage of incident, adverse event and complaint dataMarit S de Vos, Jaap F Hamming, Jolanda J C Chua-Hendriks, et al.Cancer Research|April 15, 1992
Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alphaM A Brach, H J Gruss, Y Asano, et al.Cancer Research|August 1, 1993
Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene productS de Vos, M A Brach, Y Asano, et al.AIDS (London, England)|January 10, 2014
Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort studyAnneke S de Vos, Maria Prins, Roel A Coutinho, et al.Pageof 11